COVID-19 patients presenting with ST-segment elevation myocardial infarction (STEMI) experience a high rate of stent thrombosis.

Such attributes as patient outcomes, efficiency and available resources were used to develop the list, which includes a tie at No. 10. 

Researchers tracked the outcomes of more than 45,000 patients who participated in one of four randomized trials.

Rapid reperfusion is linked to improved survival for STEMI patients, but delayed care is still prevalent. 

The authors tracked data from more than 22,000 PCI patients who participated in one of 10 randomized trials.

When patients have stable ischemic heart disease, two primary treatment options are revascularization followed by guideline-directed medical therapy (GDMT) or GDMT alone.

Operators who performed at least 16 uLMS-PCIs per year were associated with improved survival.

The device will be tested in high-risk percutaneous coronary intervention (PCI) patients.

Fractional flow reserve guidance can help cardiologists make better decisions during percutaneous coronary intervention—can it lead to better outcomes for patients with stable angina pectoris?